Other languages Hla Group Corp., Ltd.

Equities

600398

CNE0000016H3

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-05-12 pm EDT			5-day change	1st Jan Change
9.63 ^CNY	+2.99%		+5.71%	+29.78%

Apr. 29	Hla Group Corp., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 29	Hla Group Corp., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Hla Group Corp., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 29
Hla Group Corp., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 29
Ose Immuno a reçu un financement de Bpifrance	Apr. 11
HLA to Redeem Convertible Bonds Early	Mar. 19
OSE Immunotherapeutics : A suivre aujourd'hui	Nov. 22
OSE Immunotherapeutics : s'allie à GenDx pour l'essai clinique de son vascin anticancer	Nov. 21
OSE Immuno : accord de collaboration avec GenDx	Nov. 21
Hla Group Corp., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-30
Immatics' IMA203 TCR-T Program Receives Regenerative Medicine Advanced Therapy Designation	23-10-24
IDEAYA Biosciences Initiates Phase 2 Expansion of Combination Therapy for Metastatic Cutaneous Melanoma	23-10-16
Healthia Expands North American Laboratory Operations	23-10-12
OSE Immunotherapeutics : Immuno, plus forte hausse du marché SRD à la clôture du mardi 12 septembre 2023	23-09-12
OSE Immunotherapeutics : Immuno, plus forte hausse du marché SRD à la mi-séance du mardi 12 septembre 2023	23-09-12
OSE Immunotherapeutics : bondit après les résultats positifs de son vaccin anti cancer	23-09-12
Les valeurs à suivre aujourd'hui à la Bourse de Paris - Mardi 12 septembre 2023	23-09-12
OSE Immunotherapeutics' Lung Cancer Vaccine Extends Survival in Late-stage Study	23-09-12
Les valeurs à suivre demain à la Bourse de Paris - Mardi 12 septembre 2023	23-09-11
OSE Immunotherapeutics : publication des résultats positifs de phase 3 de son vaccin anti cancer	23-09-11
China Manufacturing Gloom Tempers Gains of Australian Equities	23-08-31
Healthia Receives AU$260 Million Acquisition Bid from Pacific Equity Partners	23-08-31

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Hla Group Corp., Ltd.

Equities

600398

CNE0000016H3

Other languages

Filters